Benefit-cost analysis of addiction treatment

Methodological guidelines and empirical application using the DATCAP and ASI

Michael French, Helena J. Salomé, Jody L. Sindelar, A. Thomas McLellan

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Objective. To provide detailed methodological guidelines for using the Drug Abuse Treatment Cost Analysis Program (DATCAP) and Addiction Severity Index (ASI) in a benefit-cost analysis of addiction treatment. Data Sources/Study Setting. A representative benefit-cost analysis of three outpatient programs was conducted to demonstrate the feasibility and value of the methodological guidelines. Study Design. Procedures are outlined for using resource use and cost data collected with the DATCAP. Techniques are described for converting outcome measures from the ASI to economic (dollar) benefits of treatment. Finally, principles are advanced for conducting a benefit-cost analysis and a sensitivity analysis of the estimates. Data Collection/Extraction Methods. The DATCAP was administered at three outpatient drug-free programs in Philadelphia, PA, for 2 consecutive fiscal years (1996 and 1997). The ASI was administered to a sample of 178 treatment clients at treatment entry and at 7-months postadmission. Principal Findings. The DATCAP and ASI appear to have significant potential for contributing to an economic evaluation of addiction treatment. The benefit-cost analysis and subsequent sensitivity analysis all showed that total economic benefit was greater than total economic cost at the three outpatient programs, but this representative application is meant to stimulate future economic research rather than justifying treatment per se. Conclusions. This study used previously validated, research-proven instruments and methods to perform a practical benefit-cost analysis of real-world treatment programs. The study demonstrates one way to combine economic and clinical data and offers a methodological foundation for future economic evaluations of addiction treatment.

Original languageEnglish (US)
Pages (from-to)433-455
Number of pages23
JournalHealth Services Research
Volume37
Issue number2
DOIs
StatePublished - Apr 2002

Fingerprint

cost-benefit analysis
drug abuse
addiction
Health Care Costs
Substance-Related Disorders
Cost-Benefit Analysis
Guidelines
Costs and Cost Analysis
costs
Economics
economics
Outpatients
Therapeutics
economic research
Information Storage and Retrieval
evaluation
Research
dollar
Outcome Assessment (Health Care)
drug

Keywords

  • Addiction treatment
  • ASI
  • Benefit-cost analysis
  • DATCAP

ASJC Scopus subject areas

  • Health Policy
  • Nursing(all)
  • Health(social science)
  • Health Professions(all)

Cite this

Benefit-cost analysis of addiction treatment : Methodological guidelines and empirical application using the DATCAP and ASI. / French, Michael; Salomé, Helena J.; Sindelar, Jody L.; McLellan, A. Thomas.

In: Health Services Research, Vol. 37, No. 2, 04.2002, p. 433-455.

Research output: Contribution to journalArticle

French, Michael ; Salomé, Helena J. ; Sindelar, Jody L. ; McLellan, A. Thomas. / Benefit-cost analysis of addiction treatment : Methodological guidelines and empirical application using the DATCAP and ASI. In: Health Services Research. 2002 ; Vol. 37, No. 2. pp. 433-455.
@article{73b687ea25594d11be10935265665cf3,
title = "Benefit-cost analysis of addiction treatment: Methodological guidelines and empirical application using the DATCAP and ASI",
abstract = "Objective. To provide detailed methodological guidelines for using the Drug Abuse Treatment Cost Analysis Program (DATCAP) and Addiction Severity Index (ASI) in a benefit-cost analysis of addiction treatment. Data Sources/Study Setting. A representative benefit-cost analysis of three outpatient programs was conducted to demonstrate the feasibility and value of the methodological guidelines. Study Design. Procedures are outlined for using resource use and cost data collected with the DATCAP. Techniques are described for converting outcome measures from the ASI to economic (dollar) benefits of treatment. Finally, principles are advanced for conducting a benefit-cost analysis and a sensitivity analysis of the estimates. Data Collection/Extraction Methods. The DATCAP was administered at three outpatient drug-free programs in Philadelphia, PA, for 2 consecutive fiscal years (1996 and 1997). The ASI was administered to a sample of 178 treatment clients at treatment entry and at 7-months postadmission. Principal Findings. The DATCAP and ASI appear to have significant potential for contributing to an economic evaluation of addiction treatment. The benefit-cost analysis and subsequent sensitivity analysis all showed that total economic benefit was greater than total economic cost at the three outpatient programs, but this representative application is meant to stimulate future economic research rather than justifying treatment per se. Conclusions. This study used previously validated, research-proven instruments and methods to perform a practical benefit-cost analysis of real-world treatment programs. The study demonstrates one way to combine economic and clinical data and offers a methodological foundation for future economic evaluations of addiction treatment.",
keywords = "Addiction treatment, ASI, Benefit-cost analysis, DATCAP",
author = "Michael French and Salom{\'e}, {Helena J.} and Sindelar, {Jody L.} and McLellan, {A. Thomas}",
year = "2002",
month = "4",
doi = "10.1111/1475-6773.031",
language = "English (US)",
volume = "37",
pages = "433--455",
journal = "Health Services Research",
issn = "0017-9124",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Benefit-cost analysis of addiction treatment

T2 - Methodological guidelines and empirical application using the DATCAP and ASI

AU - French, Michael

AU - Salomé, Helena J.

AU - Sindelar, Jody L.

AU - McLellan, A. Thomas

PY - 2002/4

Y1 - 2002/4

N2 - Objective. To provide detailed methodological guidelines for using the Drug Abuse Treatment Cost Analysis Program (DATCAP) and Addiction Severity Index (ASI) in a benefit-cost analysis of addiction treatment. Data Sources/Study Setting. A representative benefit-cost analysis of three outpatient programs was conducted to demonstrate the feasibility and value of the methodological guidelines. Study Design. Procedures are outlined for using resource use and cost data collected with the DATCAP. Techniques are described for converting outcome measures from the ASI to economic (dollar) benefits of treatment. Finally, principles are advanced for conducting a benefit-cost analysis and a sensitivity analysis of the estimates. Data Collection/Extraction Methods. The DATCAP was administered at three outpatient drug-free programs in Philadelphia, PA, for 2 consecutive fiscal years (1996 and 1997). The ASI was administered to a sample of 178 treatment clients at treatment entry and at 7-months postadmission. Principal Findings. The DATCAP and ASI appear to have significant potential for contributing to an economic evaluation of addiction treatment. The benefit-cost analysis and subsequent sensitivity analysis all showed that total economic benefit was greater than total economic cost at the three outpatient programs, but this representative application is meant to stimulate future economic research rather than justifying treatment per se. Conclusions. This study used previously validated, research-proven instruments and methods to perform a practical benefit-cost analysis of real-world treatment programs. The study demonstrates one way to combine economic and clinical data and offers a methodological foundation for future economic evaluations of addiction treatment.

AB - Objective. To provide detailed methodological guidelines for using the Drug Abuse Treatment Cost Analysis Program (DATCAP) and Addiction Severity Index (ASI) in a benefit-cost analysis of addiction treatment. Data Sources/Study Setting. A representative benefit-cost analysis of three outpatient programs was conducted to demonstrate the feasibility and value of the methodological guidelines. Study Design. Procedures are outlined for using resource use and cost data collected with the DATCAP. Techniques are described for converting outcome measures from the ASI to economic (dollar) benefits of treatment. Finally, principles are advanced for conducting a benefit-cost analysis and a sensitivity analysis of the estimates. Data Collection/Extraction Methods. The DATCAP was administered at three outpatient drug-free programs in Philadelphia, PA, for 2 consecutive fiscal years (1996 and 1997). The ASI was administered to a sample of 178 treatment clients at treatment entry and at 7-months postadmission. Principal Findings. The DATCAP and ASI appear to have significant potential for contributing to an economic evaluation of addiction treatment. The benefit-cost analysis and subsequent sensitivity analysis all showed that total economic benefit was greater than total economic cost at the three outpatient programs, but this representative application is meant to stimulate future economic research rather than justifying treatment per se. Conclusions. This study used previously validated, research-proven instruments and methods to perform a practical benefit-cost analysis of real-world treatment programs. The study demonstrates one way to combine economic and clinical data and offers a methodological foundation for future economic evaluations of addiction treatment.

KW - Addiction treatment

KW - ASI

KW - Benefit-cost analysis

KW - DATCAP

UR - http://www.scopus.com/inward/record.url?scp=0036551624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036551624&partnerID=8YFLogxK

U2 - 10.1111/1475-6773.031

DO - 10.1111/1475-6773.031

M3 - Article

VL - 37

SP - 433

EP - 455

JO - Health Services Research

JF - Health Services Research

SN - 0017-9124

IS - 2

ER -